• Skip to content

Ceramisphere Health

<!-- Global site tag (gtag.js) - Google Analytics --> <script async src="https://www.googletagmanager.com/gtag/js?id=UA-163800918-1"></script> <script> window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'UA-163800918-1'); </script>

  • Home
  • About
    • Ceramisphere Health
    • History
    • People
    • Facilities
    • Technology
      • Ceramisphere Encapsulation Technology
      • Key Features and Benefits
  • Pipeline
    • Pipeline Overview
    • Lidocaine Patch
    • Controlled Drug Patch
    • EGF Patch
  • Investors
    • Technology Summary
    • Opportunity
    • Market & Opportunity for Lidocaine Patches
    • Market & Opportunity for Fentanyl Patches
    • Market & Opportunity for EGF Patches and Bioactive Wound Dressings
  • News
  • Downloads
  • Contact

Technology Summary

Technology Summary

Technology Summary

Our technology provides a clear competitive edge in terms of efficacyand efficiency (at least 30 times less drug used to get the same effect) with minimum residual drug in the used patchto ensure ease of disposal. The unique protective properties of silica matrixwill allow the production of SMART multi-targeted bioactive patches. (e.g. combining growth factors like EGF, antibiotics and pain relief molecules) for the treatment of deep skin wounds such as burns.

Based on our data, our nanocomposite patch technology can:

  • Significantly extend the time of application.
  • Minimise skin irritation via drug encapsulation in protective and biocompatible silica matrix.
  • Increase the efficiency of the patch by several folds: More than 95% usage in the nanocomposite lidocaine patch.
  • Significantly lower the drug loading in the patch thus providing an economically viable and effective solution for expensive drugs (>30x).
  • Significantly reduce the residual drug in the used patch to almost nil which provides for easy disposal, especially required in the case of abuse-prone drugs like fentanyl.
  • Allow multidrug treatments in one device: Super “All in One” dressings which will allow multifaceted wound care can be developed; i.e.  faster and better healing, low scarring and improved pain management.
CERAMISPHERE HEALTH
ADVANCED DRUG DELIVERY
We are an Australian based drug delivery company focused on the development of our “zero-waste” transdermal patches for the delivery of analgesics with an emphasis on controlled drugs for pain-relief and for development of smart bioactive wound care products with minimal pain and scarring. We are seeking partners to help us progress our “zero-waste” nanocomposite patch technology through early clinical trials with a view to license the technology for specific therapeutic applications to patch or wound dressing manufacturers or pharmaceutical companies.
Read More
  • Home
  • About
  • Contact
  • Downloads
COPYRIGHT © CERAMISPHERE 2023
Privacy Policy Terms & Conditions